Does the presence of metabolic syndome influence weight loss in obese and overweight women?

Metabolic Syndrome and Related Disorders

Volumn 8, Issue 2, 2010, Pages 173-177

  Evangelou, P ^a   Tzotzas, T ^b   Christou, G ^a   Elisaf, M S ^a   Kiortsis, D N ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b PANAGIA GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LOW FAT DIET; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIET, REDUCING; FEMALE; HUMANS; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; WEIGHT LOSS;

EID: 77950621060     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2009.0066     Document Type: Article

References (25)

1. Bessesen DH. Update on obesity. J Clin Endocrinol Metab 2008;93:2027-2034.
2. James WP. The epidemiology of obesity: The size of the problem. J Intern Med 2008;263:336-352.
3. NCEP/ATP III, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
4. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-1105.
5. Filippatos TD, Kiortsis DN, Liberopoulos EN, Georgoula M, Mikhailidis DP, Elisaf MS. Effect of orlistat, micronised fenofi brate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: The FenOrli study. Curr Med Res Opin 2005;21:1997-2006.
6. Teixeira PJ, Palmeira AL, Branco TL, Martins SS, Minderico CS, Barata JT, Silva AM, Sardinha LB. Who will lose weight? A reexamination of predictors of weight loss in women. Int J Behav Nutr Phys Act 2004;1:12.
7. Bild DE, Sholinsky P, Smith DE, Lewis CE, Hardin JM, Burke GL. Correlates and predictors of weight loss in young adults: the CARDIA study. Int J Obes Relat Metab Disord 1996;20;47-55.
8. Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991;88:168-173.
9. Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C. Reduced insulin secretion: An independent predictor of body weight gain. J Clin Endocrinol Metab 1995;80:1571-1576.
10. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 1997;46:1341-1345.
11. Sigal RJ, El-Hashimy M, Martin BC, Soeldner JS, Krolewski AS, Warram JH. Acute postchallenge hyperinsulinemia predicts weight gain: A prospective study. Diabetes 1997;46;1025-1029.
12. Wedick NM, Mayer-Davis EJ, Wingard DL, Addy CL, Barrett- Connor E. Insulin resistance precedes weight loss in adults without diabetes: The Rancho Bernardo Study. Am J Epidemiol 2001;153:1199-1205.
13. McLaughlin T, Abbasi F, Carantoni M, Schaaf P, Reaven G. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. J Clin Endocrinol Metab 1999;84:578-581.
14. Pinkston MM, Poston WS, Reeves RS, Haddock CK, Taylor JE, Foreyt JP. Does metabolic syndrome mitigate weight loss in overweight Mexican American women treated for 1-year with orlistat and lifestyle modification? Eat Weight Disord 2006;11:e35-e41.
15. Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome- from insulin resistance to obesity and diabetes. Endocrinol Metab Clin N Am 2008;37:559-579, vii.
16. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629-636.
17. Folsom AR, Vitelli LL, Lewis CE, Schreiner PJ, Watson RL, Wagenknecht LE. Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting fi ndings from the CARDIA and ARIC study cohorts. Int J Obes Relat Metab Disord 1998;22:48-54.
18. Hoag S, Marshall JA, Jones RH, Hamman RF. High fasting insulin levels associated with lower rates of weight gain in persons with normal glucose tolerance: The San Luis Valley Diabetes Study. Int J Obes Relat Metab Disord 1995;19:175-180.
19. Meek SE, Nair KS, Jensen MD. Insulin regulation of regional free fatty acid metabolism. Diabetes 1999;48:10-14.
20. Bolinder J, Kager L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 1983;32:117-123.
21. Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 2003;24:276-283.
22. Filippatos TD, Gazi IF, Liberopoulos EN, Athyros VG, Elisaf MS, Tselepis AD, Kiortsis DN. The effect of orlistat and fenofi brate, alone or in combination, on small dense LDL and lipoproteinassociated phospholipase A2 in obese patients with metabolic syndrome. Atherosclerosis 2007;193:428-437.
23. Sartorio A, Lafortuna CL, Vangeli V, Tavani A, Bosetti C, La Vecchia C. Short-term changes of cardiovascular risk factors after a non-pharmacological body weight reduction program. Eur J Clin Nutr 2001;55:865-869.
24. Noakes M, Keogh JB, Foster PR, Clifton PM. Effect of an energyrestricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr 2005;81:1298-1306.
25. Heitzmann CA, Kaplan RM, Wilson DK, Sandler J. Sex differences in weight loss among adults with type II diabetes mellitus. J Behav Med 1987;10:197-211.